News

11/15/19

Sixty-seven oral and poster presentations were showcased at the 13th annual Neuroscience Research Day of the neuroscience program and the Buffalo Chapter of the Society for Neuroscience (SfN).

11/12/19

Atrophied brain lesion volume is the only marker from MRI scans that can accurately predict which patients will progress to the most severe form of multiple sclerosis (MS), according to a retrospective, five-year study of 1,314 MS patients.

10/31/19

The new program, leading to a Bachelor of Science degree, was developed as a collaboration between the Jacobs School of Medicine and Biomedical Sciences and the College of Arts and Sciences.

7/1/19

The PhD Program in Biomedical Sciences (PPBS) conducted its third annual white coat ceremony to recognize 19 students from the Class of 2018-2019 — 14 doctoral students and five MD-PhD students — who completed their first year in the program and are moving on to their research laboratory match.

6/5/19

Twenty-nine doctoral, 36 master’s and 154 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.

12/18/18

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

10/25/18

Chelsey Reed, a student in the MD-PhD Program, has been awarded a prestigious fellowship from the National Institutes of Health (NIH).

9/13/18

A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.

9/10/18

David Dietz, PhD, associate professor, has been appointed chair of the Department of Pharmacology and Toxicology.